Tag: biosimilars
Global Biosimilar Markets: Europe vs United States in 2026
Compare the biosimilar markets in Europe and the US. Explore regulatory differences, market sizes, and growth trends shaping the future of biologic cost reduction.
How Generic Medications Save You Money: A Guide to Lowering Healthcare Costs
Discover how switching to generic medications can slash your healthcare costs. Learn about FDA standards, biosimilars, and practical tips to save money at the pharmacy.
Recent Authorized Generic Approvals: Current Options and Market Trends
Explore the current market status of authorized generics, including recent 2025 approvals, pricing differences compared to traditional generics, and how to identify them.
Immunogenicity in Biosimilars: Understanding Immune Response Differences
Explore why immunogenicity may differ in biosimilars compared to reference biologics. Learn about anti-drug antibodies, manufacturing impacts, and clinical safety data.
Future Biosimilars: Upcoming Patent Expirations and Market Entry
Upcoming patent expirations for major biologics like Keytruda and Eylea will trigger a wave of biosimilars, cutting costs and reshaping healthcare. Learn how these complex drugs differ from generics, who's developing them, and what it means for patients and providers.